Dabrafenib-induced pemphigoid-like reaction

Clin Exp Dermatol. 2018 Mar;43(2):222-224. doi: 10.1111/ced.13309. Epub 2017 Dec 8.

Authors

R Satta¹, G Onnis¹, S Gunnella¹, M A Montesu¹, A F Agnoletti², E Cozzani²

Affiliations

¹ Department of Surgical, Microsurgical and Medical Sciences, Unit of Dermatology, University of Sassari, Sassari, Italy.
² Section of Dermatology, University of Genoa Di S Sal, RCCS San Martino Hospital-IST, Genoa, Italy.

PMID: 29222830
DOI: 10.1111/ced.13309

No abstract available

Publication types

Case Reports

MeSH terms

Aged, 80 and over
Antineoplastic Agents / adverse effects*
Humans
Imidazoles / adverse effects*
Male
Oximes / adverse effects*
Pemphigoid, Bullous / chemically induced*
Protein Kinase Inhibitors / adverse effects*

Substances

Antineoplastic Agents
Imidazoles
Oximes
Protein Kinase Inhibitors
dabrafenib